Health Stocks in Motion
Updated from 3:33 p.m. EDT
Shares of Gentiva Health Services (GTIV) were among the worst-performing health-related stocks Thursday, falling 16.4% after the company posted first-quarter earnings and sales that disappointed Wall Street.
The provider of home health services posted earnings of $4.1 million, or 17 cents a share, on sales of $207.1 million. Analysts surveyed by Thomson First Call were expecting earnings of 21 cents a share on sales of $217.8 million. A year ago the company reported adjusted earnings of $4.3 million, or 16 cents a share, on sales of $205.9 million, which excludes special items.
Looking ahead, Gentiva now expects 2005 earnings of 75 cents to 83 cents a share, up from previous guidance of 72 cents to 80 cents a share. Part of the company's upward revision is due to a delay in the implementation of accounting rules on stock-based compensation, which will now go into affect during fiscal 2006, instead of the second half of 2005. The accounting change would have increased expenses by 6 cents to 8 cents a share.The company also said that its outlook is based on the acquisition of Heritage Home Care Services, a conservative view regarding sales from its Cigna relationship -- based on first-quarter results -- and the company's decision to invest in clinical capacity and branch operations. Gentiva backed its 2005 sales estimate of $870 million to $890 million. Analysts are expecting earnings of 83 cents a share on sales of $893 million. Shares traded down $3.42 to $17.41. Bentley Pharmaceuticals (BNT) rose 22.6% after the company posted first-quarter results that easily topped expectations. The drug delivery company earned $2.2 million, or 10 cents a share, on sales of $24.2 million. Analysts were expecting earnings of 5 cents a share on sales of $20.1 million. Results were helped by sales volume growth in Spain, a strengthening of the euro against the dollar and continued growth in pharmaceutical sales to licensees, both in Spain and outside of Spain. A year ago the company earned $800,000, or 4 cents a share, on sales of $17.3 million. Shares traded up $1.71 to $9.29.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV